Cargando…
Balancing adipocyte production and lipid metabolism to treat obesity-induced diabetes with a novel proteoglycan from Ganoderma lucidum
Obesity is often accompanied by metabolic disorder and insulin resistance, resulting in type 2 diabetes. Based on previous findings, FYGL, a natural hyperbranched proteoglycan extracted from the G. lucidum fruiting body, can decrease blood glucose and reduce body weight in diabetic mice. In this art...
Autores principales: | Wang, YingXin, Yu, Fanzhen, Zheng, Xinru, Li, Jiaqi, Zhang, Zeng, Zhang, Qianqian, Chen, Jieying, He, Yanming, Yang, Hongjie, Zhou, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10408226/ https://www.ncbi.nlm.nih.gov/pubmed/37553709 http://dx.doi.org/10.1186/s12944-023-01880-6 |
Ejemplares similares
-
Interaction and Inhibition of a Ganoderma
lucidum Proteoglycan on PTP1B Activity for Anti-diabetes
por: Yu, Fanzhen, et al.
Publicado: (2021) -
Effects of a Ganoderma lucidum Proteoglycan
on Type 2 Diabetic Rats and the Recovery of Rat Pancreatic
Islets
por: Yu, Fanzhen, et al.
Publicado: (2023) -
Proteoglycan Extracted
from Ganoderma lucidum Ameliorated Diabetes-Induced
Muscle Atrophy via the AMPK/SIRT1 Pathway
In Vivo and In Vitro
por: Li, Jiaqi, et al.
Publicado: (2023) -
Inhibition on α-Glucosidase Activity and Non-Enzymatic Glycation by an Anti-Oxidative Proteoglycan from Ganoderma lucidum
por: Zhang, Ying, et al.
Publicado: (2022) -
Pancreatic cancer cell apoptosis is induced by a proteoglycan extracted from Ganoderma lucidum
por: Wu, Xiao, et al.
Publicado: (2021)